2022 Hematology and Oncology Best Practices Virtual - Hematology Sessions (5 Days)
COURSE HIGHLIGHTS
There are several unique features that set this course apart from the others:
- Expert Faculty- Our faculty, unmatched in experience and expertise, will present the latest scientific findings in Hematology and Oncology, and best practices in the advances in cancer prevention, diagnosis, treatment, and survivorship
- Daily Board Review Sessions- Allows attendees to gauge their knowledge base and become familiar with board-type questions
- Access to high quality video presentations featuring the nation's leading clinician-educators (streaming media). You will have access to this course until Sunday, December 31, 2023
- All content can be conveniently accessed from your computer, mobile device, or smartphone
- Access to the course Electronic Syllabus and Slide Handouts
- CME Credits and MOC Points
Attending 2022 HEMONC is an excellent way to fulfill your continuing medical education requirements. 2022 HEMONC attendees can also earn MOC points by attending sessions, participating in the daily lunch review sessions, and completing the post-course Learner Assessment.
Target Audience
This course is ideal for physicians preparing to take the Hematology and Oncology certification exams as well as for Oncology Nurse Practitioners, Nurses, Physician Assistants, Pharmacists, Advanced Practice Providers, Allied Professionals and other Healthcare Providers desiring a comprehensive review of hematology and medical oncology standards of care.
Learning Objectives
At the conclusion of the Hematology Sessions, the successful learner will be able to:
Hematology
- Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors
- Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies
- Understand blood and marrow morphology and hematopathology
- Understand red cell disorders
Hematologic Malignancies
- Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs
- Be familiar with the diagnosis, evaluation, and management of hematologic malignancies
- Identify strategies for taking the board examinations
Course Syllabus
Course Director: Robert S. Siegel, MD
Thursday, August 11, 2022- Day 1: Hematology Session | |||
TIME | TOPIC | PRESENTER | |
07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees | |
07:00 AM – 08:00 AM | Breakfast Product Theater Hosted by (tbc) | Exhibitors | Attendees | |
08:00 AM – 08:05 AM | Welcome | Housekeeping Notes | Robert S. Siegel, MD | |
08:05 AM – 08:55 AM | Biology of Hematopoiesis | Jerry L. Spivak, MD, MACP | |
08:55 AM – 09:55 AM | Iron Deficiency and Overload | Victor R. Gordeuk, MD | |
09:55 AM – 10:15 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees | |
10:15 AM – 11:15 AM | Hemoglobinopathies | Victor Gordeuk, MD | |
11:15 AM – 12:00 PM | Anemia of Chronic Illness | Vera Malkovska, MD | |
12:00 PM – 12:30 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees | |
12:30 PM – 02:00 PM | Lunch Review Session 1: | Moderator: Dr. R. Siegel | |
02:00 PM – 02:30 PM | Porphyrias | Victor Gordeuk, MD | |
02:30 PM – 03:15 PM | Megaloblastic and Sideroblastic Anemias | Vera Malkovska, MD | |
03:15 PM – 04:00 PM | Hemolytic Anemia | Imad A. Tabbara, MD | |
04:00 PM – 04:20 PM | Break | Visit Exhibit Hall | Exhibitors | Attendees | |
04:20 PM – 05:00 PM | Red Cell Enzymes, Membranes, | Imad A. Tabbara, MD | |
05:00 PM – 05:45 PM | Sickling Disorders | Santosh Saraf, MD | |
05:45 PM – 05:50 PM | Closing Reminders for the End of the Day |
| |
05:50 PM – 07:00 PM | Visit Exhibit Hall | Exhibitors | Attendees | |
05:50 PM – 09:00 PM | Dinner Product Forum Hosted by (tbc) | Exhibitors | Attendees | |
Friday, August 12, 2022- Day 2: Hematology Session | ||
TIME | TOPIC | PRESENTER |
07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
07:00 AM – 08:00 AM | Breakfast Product Theater Hosted by (tbc) | Exhibitors | Attendees |
08:00 AM – 08:05 AM | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:05 AM – 08:45 AM | Mechanisms for Clotting | Nigel Key, MD |
08:45 AM – 09:20 AM | The Hemophilias | Nigel Key, MD |
09:20 AM – 10:05 AM | Von Willebrand’s Disease | Alice Ma, MD, FACP |
10:05 AM – 10:25 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
10:25 AM – 11:10 AM | Acquired Disorders of Coagulation | Alice Ma, MD, FACP |
11:10 AM – 12:15 PM | Hypercoagulable States | Kenneth A. Bauer, MD |
12:15 PM – 12:45 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
12:45 PM – 02:15 PM | Lunch Review Session 2: | Moderator: Dr. R. Siegel |
02:15 PM – 03:00 PM | ITP and Drug-Induced Thrombocytopenia | Robert S. Siegel, MD |
03:00 PM – 04:00 PM | Qualitative Platelet Defects | A. Koneti Rao, MBBS |
04:00 PM – 04:20 PM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
04:20 PM – 05:05 PM | Oral Anticoagulants and Antithrombotic Therapy | B. Gail Macik, MD |
05:05 PM – 05:40 PM | Parenteral Antithrombotics and Thrombolytic Therapy | B. Gail Macik, MD |
05:40 PM – 05:45 PM | Closing Reminders for the End of the Day |
|
05:45 PM – 06:45 PM | Visit Exhibit Hall | Exhibitors | Attendees |
05:45 PM – 08:45 PM | Dinner Product Forum Hosted by (tbc) | Exhibitors | Attendees |
Saturday, August 13, 2022- Day 3: Hematology Session | ||
TIME | TOPIC | PRESENTER |
07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
07:00 AM – 08:00 AM | Breakfast Product Theater Hosted by (tbc) | Exhibitors | Attendees |
08:00 AM – 08:05 AM | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
08:05 AM – 09:00 AM | Transfusion Medicine | Speaker- (tba) |
09:00 AM – 09:35 AM | Platelet Alloimmunization | Speaker- (tba) |
09:35 AM – 10:15 AM | White Cell Disorders | Amy DeZern, MD, MHS |
10:15 AM – 10:35 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
10:35 AM – 11:30 AM | Bone Marrow Failure | Amy DeZern, MD, MHS |
11:30 AM – 12:00 PM | Consumptive Thrombohemorrhagic Disorders (DIC, TTP, HUS) | Michele P. Lambert, MD, MSTR |
12:00 PM – 12:30 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
12:30 PM – 02:15 PM | Lunch Review Session 3: | Moderator: Dr. R. Siegel |
02:15 PM – 03:15 PM | DIC, HIT, and Limb Gangrene | Theodore (Ted) Warkentin, MD |
03:15 PM – 04:00 PM | Hematologic Complications | Robert S. Siegel, MD |
04:00 PM – 04:20 PM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
04:20 PM – 05:10 PM | ABO Incompatibility and Other Transfusion-Related Issues in Hematopoietic Transplantation | Shelley Kalsi, MD |
05:10 PM – 05:55 PM | Review of Cellular Morphology | Donald Karcher, MD |
05:55 PM – 06:00 PM | Closing Reminders for the End of the Day |
|
06:00 PM – 07:00 PM | Visit Exhibit Hall | Exhibitors | Attendees |
06:00 PM – 09:00 PM | Dinner Product Forum Hosted by (tbc) | Exhibitors | Attendees |
Sunday, August 14, 2022- Day 4: Hematologic Malignancies Session | ||
TIME | TOPIC | PRESENTER |
06:30 AM – 07:30 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
06:30 AM – 07:30 AM | Breakfast Product Theater Hosted by (tbc) | Exhibitors | Attendees |
07:30 AM – 07:35 AM | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
07:35 AM– 08:35 AM | Pathology of Lymphomas | L. Jeffrey Medeiros, MD |
08:35 AM – 09:35 AM | Non-Hodgkin’s Lymphoma | John Leonard, MD |
09:35 AM – 09:55 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
09:55 AM – 10:50 AM | Multiple Myeloma, Plasmacytoma, | S. Vincent Rajkumar, MD |
10:50 AM – 11:30 AM | Hodgkin’s Lymphoma | John Leonard, MD |
11:30 AM – 12:15 PM | Acute Lymphocytic Leukemia | Hagop Kantarjian, MD |
12:15 PM – 12:45 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
12:45 PM – 02:30 PM | Lunch Review Session 4: | Moderator: Dr. R. Siegel |
02:30 PM – 3:15 PM | Chronic Myeloid Leukemia | Hagop Kantarjian, MD |
03:15 PM – 04:00 PM | Chronic Lymphocytic Leukemia | Matthew Davids, MD |
04:00 PM – 04:20 PM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
04:20 PM – 05:05 PM | Myelodysplasia | Mikkael Sekeres, MD, MS |
05:05 PM – 05:55 PM | Waldenstrom’s Macroglobulinemia | Morie A. Gertz, MD, MACP |
05:55 PM – 06:00 PM | Closing Reminders for the End of the Day |
|
06:00 PM – 07:00 PM | Visit Exhibit Hall | Exhibitors | Attendees |
06:00 PM – 09:00 PM | Dinner Product Forum Hosted by (tbc) | Exhibitors | Attendees |
Monday, August 15, 2022- Day 5: Hematologic Malignancies Session | |||
TIME | TOPIC | PRESENTER |
|
07:00 AM – 08:00 AM | Breakfast | Visit Exhibit Hall | Exhibitors | Attendees |
|
07:00 AM – 08:00 AM | Breakfast Product Theater Hosted by (tbc) | Exhibitors | Attendees |
|
08:00 AM – 08:05 AM | Welcome | Housekeeping Notes | Robert S. Siegel, MD |
|
08:05 AM – 09:05 AM | Acute Myeloid Leukemia | Richard Stone, MD |
|
09:05 AM – 09:50 AM | Bone Marrow Transplantation | Forrest M. Stewart, MD |
|
09:50 AM – 10:10 AM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
|
10:10 AM – 11:10 AM | Myeloproliferative Neoplasms | Ayalew Tefferi, MD |
|
11:10 AM – 12:10 PM | Pharmacology I | Edward Chu, MD, MMS |
|
12:10 PM – 12:40 PM | Lunch | Visit Exhibit Hall | Exhibitors | Attendees |
|
12:40 PM – 02:30 PM | Lunch Review Session 5: | Moderator: Dr. R. Siegel |
|
02:20 PM – 03:05 PM | Pharmacology II | Edward Chu, MD, MMS |
|
03:05 PM – 03:35 PM | Pharmacology III | Edward Chu, MD, MMS |
|
03:35 PM – 03:55 PM | Break | Visit Exhibit Hall | Exhibitors | Attendees |
|
03:55 PM – 04:40 PM | Palliative Care | Erica Schockett, MD |
|
04:40 PM – 05:30 PM | Next Gen Sequencing for the Diagnosis and Treatment of Neoplastic Disorders | Howard A. Burris III, MD, FACP, FASCO |
|
05:30 PM – 06:10 PM | T Cell Therapies for Cancer | Catherine Bollard, MBChB, MD, FRACP, FRCPA |
|
06:10 PM – 06:15 PM | Closing Reminders for the End of the Day |
|
|
06:15 PM – 07:15 PM | Visit Exhibit Hall | Exhibitors | Attendees |
|
06:15 PM – 09:15 PM | Dinner Product Forum Hosted by (tbc) | Exhibitors | Attendees |
|
ACCREDITATION
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
PHYSICIAN CME CREDIT
The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 53.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 53.50 ABIM MOC 2
- 53.50 AMA PRA Category 1 Credit™The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 53.50 Completion
Price
REGISTRATION FEES
When you register for the HEMONC Best Practices course, the registration fee includes:
- Access to the LIVE Educational Sessions and Board Review Sessions
- Access Online to the Course Materials (course electronic syllabus and PDF slide handouts)
- Access to Archived Session Recordings until Saturday, December 31, 2023
- CME Credit and MOC Points
VIRTUAL registration fees
HEmATOLOGY SESSIONS | Early | Late | Group | Group |
Physicians | $1,100.00 | $1,300.00 | $2,375.00 | $3,500.00 |
Residents | Fellows | $850.00 | $1,000.00 | $1,875.00 | $2,750.00 |
Nurses | Pharmacists | APN | APA | Advanced Practice Providers | Allied Professionals and Other Healthcare Providers | $425.00 | $525.00 | $875.00 | $1,250.00 |
Industry | $1,525.00 | $1,800.00 | N/A | N/A |
purchase disclaimer
- Please note that the Ethos CE system is designed to track individual learning. The learning system does not permit shared logins; any attempt of this activity will be monitored and your subscription will be at risk to be suspended at GW's discretion.
ATTENDEE INQUIRIES | frequently asked questions
- Please contact the FINA Logistics Conference Services Team at HEMONCBP_Inquiries@finaww.com, if you have any questions or you can refer to the FAQ document.